Skip to main content

Table 2 Staging of the participants for diabetic kidney disease

From: Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitus

Staging for diabetic kidney diasese

Sitagliptin (n = 17)

Control (n = 9)

Time (months)

0 M

120 M

0 M

120 M

Stage I

8

14

4

2

Stage II

7

2

4

6

Stage III

2

1

1

1

Stage IV

0

0

0

0

Stage V

0

0

0

0

  1. Stage I: ACR < 30, Stage II: ACR30 ~ 300, Stage III: ACR > 300
  2. ACR albumin creatinine ratio